Johnson & Johnson
Beyond the Courtroom: Analyzing the Financial Shockwaves of Johnson & Johnson’s Talc Litigation
A new UK lawsuit against Johnson & Johnson highlights the multi-billion dollar financial fallout from its talc litigation, impacting its stock and investors.
J&J’s Next Big Move: Why the Orthopaedics Spinoff Signals a New Era in Healthcare Investing
J&J plans to spin off its orthopaedics unit, a major strategic shift to focus on high-growth pharma and MedTech, reshaping its future and the market.